Efficacy and safety of anlotinib-based treatment in metastatic breast cancer patients.

MLA

Qian, Yu, et al. “Efficacy and Safety of Anlotinib-Based Treatment in Metastatic Breast Cancer Patients.” Frontiers in Oncology, vol. 12, Dec. 2022, p. 1042451. EBSCOhost, https://doi.org/10.3389/fonc.2022.1042451.

APA

Qian, Y., Lou, K., Zhou, H., Zhang, L., & Yuan, Y. (2022). Efficacy and safety of anlotinib-based treatment in metastatic breast cancer patients. Frontiers in Oncology, 12, 1042451. https://doi.org/10.3389/fonc.2022.1042451

Chicago

Qian, Yu, Kexin Lou, Hao Zhou, Lili Zhang, and Yuan Yuan. 2022. “Efficacy and Safety of Anlotinib-Based Treatment in Metastatic Breast Cancer Patients.” Frontiers in Oncology 12 (December): 1042451. doi:10.3389/fonc.2022.1042451.